HEADER HYDROLASE/HYDROLASE INHIBITOR 09-JAN-21 7LC4 TITLE CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA PBP3 IN COMPLEX WITH TITLE 2 GAMMA-LACTAM YU253911 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDOGLYCAN D,D-TRANSPEPTIDASE FTSI; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PENICILLIN-BINDING PROTEIN 3,PBP-3; COMPND 5 EC: 3.4.16.4; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: PBPB, FTSI, FTSI_2; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PBP3, GAMMA-LACTAM, INHIBITOR COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.VAN DEN AKKER,V.KUMAR REVDAT 3 18-OCT-23 7LC4 1 REMARK REVDAT 2 19-MAY-21 7LC4 1 JRNL REVDAT 1 28-APR-21 7LC4 0 JRNL AUTH J.A.GOLDBERG,V.KUMAR,E.J.SPENCER,D.HOYER,S.H.MARSHALL, JRNL AUTH 2 A.M.HUJER,K.M.HUJER,C.R.BETHEL,K.M.PAPP-WALLACE,F.PEREZ, JRNL AUTH 3 M.R.JACOBS,D.VAN DUIN,B.N.KREISWIRTH,F.VAN DEN AKKER, JRNL AUTH 4 M.S.PLUMMER,R.A.BONOMO JRNL TITL A GAMMA-LACTAM SIDEROPHORE ANTIBIOTIC EFFECTIVE AGAINST JRNL TITL 2 MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA, KLEBSIELLA JRNL TITL 3 PNEUMONIAE, AND ACINETOBACTER SPP. JRNL REF EUR.J.MED.CHEM. V. 220 13436 2021 JRNL REFN ISSN 0223-5234 JRNL PMID 33933754 JRNL DOI 10.1016/J.EJMECH.2021.113436 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 32335 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1770 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2169 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2010 REMARK 3 BIN FREE R VALUE SET COUNT : 141 REMARK 3 BIN FREE R VALUE : 0.2370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3578 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 193 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.171 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.160 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.104 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.665 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3751 ; 0.010 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3555 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5113 ; 1.656 ; 1.648 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8226 ; 1.353 ; 1.571 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 485 ; 6.920 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 196 ;31.214 ;20.612 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 603 ;15.685 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;21.494 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 489 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4269 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 780 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7LC4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000254062. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34157 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 12.50 REMARK 200 R MERGE (I) : 0.15800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 12.60 REMARK 200 R MERGE FOR SHELL (I) : 1.15900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3PBO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.2 M MGCL2, 0.1 M TRIS REMARK 280 PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.88250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.39950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.33050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.39950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.88250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.33050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 42 REMARK 465 GLY A 43 REMARK 465 HIS A 44 REMARK 465 HIS A 45 REMARK 465 HIS A 46 REMARK 465 HIS A 47 REMARK 465 HIS A 48 REMARK 465 HIS A 49 REMARK 465 ALA A 50 REMARK 465 ARG A 51 REMARK 465 SER A 52 REMARK 465 VAL A 53 REMARK 465 ARG A 54 REMARK 465 HIS A 55 REMARK 465 ILE A 56 REMARK 465 LYS A 192 REMARK 465 ARG A 193 REMARK 465 GLN A 194 REMARK 465 VAL A 195 REMARK 465 LEU A 196 REMARK 465 LYS A 197 REMARK 465 ASP A 198 REMARK 465 ARG A 199 REMARK 465 ARG A 200 REMARK 465 GLY A 201 REMARK 465 ARG A 202 REMARK 465 VAL A 203 REMARK 465 ILE A 204 REMARK 465 LYS A 205 REMARK 465 ASP A 206 REMARK 465 VAL A 207 REMARK 465 GLN A 208 REMARK 465 VAL A 209 REMARK 465 THR A 210 REMARK 465 LYS A 211 REMARK 465 ASN A 212 REMARK 465 ASN A 275 REMARK 465 LEU A 276 REMARK 465 SER A 492 REMARK 465 VAL A 493 REMARK 465 GLY A 494 REMARK 465 THR A 495 REMARK 465 LYS A 496 REMARK 465 GLY A 497 REMARK 465 TYR A 498 REMARK 465 ARG A 499 REMARK 465 GLU A 500 REMARK 465 THR A 562 REMARK 465 ALA A 563 REMARK 465 THR A 564 REMARK 465 GLU A 565 REMARK 465 GLN A 566 REMARK 465 GLN A 567 REMARK 465 GLN A 568 REMARK 465 VAL A 569 REMARK 465 ASN A 570 REMARK 465 ALA A 571 REMARK 465 ALA A 572 REMARK 465 PRO A 573 REMARK 465 ALA A 574 REMARK 465 LYS A 575 REMARK 465 GLY A 576 REMARK 465 GLY A 577 REMARK 465 ARG A 578 REMARK 465 GLY A 579 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 121 CG CD OE1 OE2 REMARK 470 ARG A 274 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 875 O HOH A 893 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLN A 98 CB - CA - C ANGL. DEV. = 14.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 119 53.98 -118.63 REMARK 500 PRO A 320 34.82 -97.55 REMARK 500 ARG A 338 -86.82 -121.41 REMARK 500 SER A 349 68.16 24.86 REMARK 500 ASN A 427 41.70 -88.74 REMARK 500 ASP A 515 83.62 -169.30 REMARK 500 REMARK 500 REMARK: NULL DBREF 7LC4 A 50 579 UNP Q51504 Q51504_PSEAI 50 579 SEQADV 7LC4 MET A 42 UNP Q51504 EXPRESSION TAG SEQADV 7LC4 GLY A 43 UNP Q51504 EXPRESSION TAG SEQADV 7LC4 HIS A 44 UNP Q51504 EXPRESSION TAG SEQADV 7LC4 HIS A 45 UNP Q51504 EXPRESSION TAG SEQADV 7LC4 HIS A 46 UNP Q51504 EXPRESSION TAG SEQADV 7LC4 HIS A 47 UNP Q51504 EXPRESSION TAG SEQADV 7LC4 HIS A 48 UNP Q51504 EXPRESSION TAG SEQADV 7LC4 HIS A 49 UNP Q51504 EXPRESSION TAG SEQRES 1 A 538 MET GLY HIS HIS HIS HIS HIS HIS ALA ARG SER VAL ARG SEQRES 2 A 538 HIS ILE ALA ILE PRO ALA HIS ARG GLY LEU ILE THR ASP SEQRES 3 A 538 ARG ASN GLY GLU PRO LEU ALA VAL SER THR PRO VAL THR SEQRES 4 A 538 THR LEU TRP ALA ASN PRO LYS GLU LEU MET THR ALA LYS SEQRES 5 A 538 GLU ARG TRP PRO GLN LEU ALA ALA ALA LEU GLY GLN ASP SEQRES 6 A 538 THR LYS LEU PHE ALA ASP ARG ILE GLU GLN ASN ALA GLU SEQRES 7 A 538 ARG GLU PHE ILE TYR LEU VAL ARG GLY LEU THR PRO GLU SEQRES 8 A 538 GLN GLY GLU GLY VAL ILE ALA LEU LYS VAL PRO GLY VAL SEQRES 9 A 538 TYR SER ILE GLU GLU PHE ARG ARG PHE TYR PRO ALA GLY SEQRES 10 A 538 GLU VAL VAL ALA HIS ALA VAL GLY PHE THR ASP VAL ASP SEQRES 11 A 538 ASP ARG GLY ARG GLU GLY ILE GLU LEU ALA PHE ASP GLU SEQRES 12 A 538 TRP LEU ALA GLY VAL PRO GLY LYS ARG GLN VAL LEU LYS SEQRES 13 A 538 ASP ARG ARG GLY ARG VAL ILE LYS ASP VAL GLN VAL THR SEQRES 14 A 538 LYS ASN ALA LYS PRO GLY LYS THR LEU ALA LEU SER ILE SEQRES 15 A 538 ASP LEU ARG LEU GLN TYR LEU ALA HIS ARG GLU LEU ARG SEQRES 16 A 538 ASN ALA LEU LEU GLU ASN GLY ALA LYS ALA GLY SER LEU SEQRES 17 A 538 VAL ILE MET ASP VAL LYS THR GLY GLU ILE LEU ALA MET SEQRES 18 A 538 THR ASN GLN PRO THR TYR ASN PRO ASN ASN ARG ARG ASN SEQRES 19 A 538 LEU GLN PRO ALA ALA MET ARG ASN ARG ALA MET ILE ASP SEQRES 20 A 538 VAL PHE GLU PRO GLY SER THR VAL LYS PRO PHE SER MET SEQRES 21 A 538 SER ALA ALA LEU ALA SER GLY ARG TRP LYS PRO SER ASP SEQRES 22 A 538 ILE VAL ASP VAL TYR PRO GLY THR LEU GLN ILE GLY ARG SEQRES 23 A 538 TYR THR ILE ARG ASP VAL SER ARG ASN SER ARG GLN LEU SEQRES 24 A 538 ASP LEU THR GLY ILE LEU ILE LYS SER SER ASN VAL GLY SEQRES 25 A 538 ILE SER LYS ILE ALA PHE ASP ILE GLY ALA GLU SER ILE SEQRES 26 A 538 TYR SER VAL MET GLN GLN VAL GLY LEU GLY GLN ASP THR SEQRES 27 A 538 GLY LEU GLY PHE PRO GLY GLU ARG VAL GLY ASN LEU PRO SEQRES 28 A 538 ASN HIS ARG LYS TRP PRO LYS ALA GLU THR ALA THR LEU SEQRES 29 A 538 ALA TYR GLY TYR GLY LEU SER VAL THR ALA ILE GLN LEU SEQRES 30 A 538 ALA HIS ALA TYR ALA ALA LEU ALA ASN ASP GLY LYS SER SEQRES 31 A 538 VAL PRO LEU SER MET THR ARG VAL ASP ARG VAL PRO ASP SEQRES 32 A 538 GLY VAL GLN VAL ILE SER PRO GLU VAL ALA SER THR VAL SEQRES 33 A 538 GLN GLY MET LEU GLN GLN VAL VAL GLU ALA GLN GLY GLY SEQRES 34 A 538 VAL PHE ARG ALA GLN VAL PRO GLY TYR HIS ALA ALA GLY SEQRES 35 A 538 LYS SER GLY THR ALA ARG LYS VAL SER VAL GLY THR LYS SEQRES 36 A 538 GLY TYR ARG GLU ASN ALA TYR ARG SER LEU PHE ALA GLY SEQRES 37 A 538 PHE ALA PRO ALA THR ASP PRO ARG ILE ALA MET VAL VAL SEQRES 38 A 538 VAL ILE ASP GLU PRO SER LYS ALA GLY TYR PHE GLY GLY SEQRES 39 A 538 LEU VAL SER ALA PRO VAL PHE SER LYS VAL MET ALA GLY SEQRES 40 A 538 ALA LEU ARG LEU MET ASN VAL PRO PRO ASP ASN LEU PRO SEQRES 41 A 538 THR ALA THR GLU GLN GLN GLN VAL ASN ALA ALA PRO ALA SEQRES 42 A 538 LYS GLY GLY ARG GLY HET XVG A 601 49 HETNAM XVG 1-[(2S)-2-{[(2Z)-2-(2-AMINO-5-CHLORO-1,3-THIAZOL-4-YL)- HETNAM 2 XVG 2-{[(2-CARBOXYPROPAN-2-YL)OXY]IMINO}ACETYL]AMINO}-3- HETNAM 3 XVG OXOPROPYL]-4-{[2-(5,6-DIHYDROXY-1,3-DIOXO-1,3-DIHYDRO- HETNAM 4 XVG 2H-ISOINDOL-2-YL)ETHYL]CARBAMOYL}-2,5-DIHYDRO-1H- HETNAM 5 XVG PYRAZOLE-3-CARBOXYLIC ACID FORMUL 2 XVG C27 H27 CL N8 O12 S FORMUL 3 HOH *193(H2 O) HELIX 1 AA1 ASN A 85 MET A 90 1 6 HELIX 2 AA2 THR A 91 GLU A 94 5 4 HELIX 3 AA3 ARG A 95 LEU A 103 1 9 HELIX 4 AA4 ASP A 106 GLN A 116 1 11 HELIX 5 AA5 THR A 130 ALA A 139 1 10 HELIX 6 AA6 ALA A 157 VAL A 160 5 4 HELIX 7 AA7 VAL A 161 GLY A 166 1 6 HELIX 8 AA8 GLY A 177 PHE A 182 1 6 HELIX 9 AA9 PHE A 182 GLY A 188 1 7 HELIX 10 AB1 ASP A 224 ASN A 242 1 19 HELIX 11 AB2 GLN A 277 ARG A 282 5 6 HELIX 12 AB3 ASN A 283 ASP A 288 1 6 HELIX 13 AB4 PRO A 292 THR A 295 5 4 HELIX 14 AB5 VAL A 296 SER A 307 1 12 HELIX 15 AB6 LEU A 342 LYS A 348 1 7 HELIX 16 AB7 SER A 350 GLY A 362 1 13 HELIX 17 AB8 GLY A 362 VAL A 373 1 12 HELIX 18 AB9 PRO A 398 TYR A 407 1 10 HELIX 19 AC1 THR A 414 ASN A 427 1 14 HELIX 20 AC2 SER A 450 ALA A 467 1 18 HELIX 21 AC3 VAL A 471 GLN A 475 5 5 HELIX 22 AC4 PHE A 533 SER A 538 1 6 HELIX 23 AC5 SER A 538 MET A 553 1 16 SHEET 1 AA1 3 ILE A 123 LEU A 129 0 SHEET 2 AA1 3 PRO A 72 ALA A 84 -1 N LEU A 82 O LEU A 125 SHEET 3 AA1 3 VAL A 145 PHE A 154 -1 O ARG A 152 N THR A 77 SHEET 1 AA2 4 ILE A 123 LEU A 129 0 SHEET 2 AA2 4 PRO A 72 ALA A 84 -1 N LEU A 82 O LEU A 125 SHEET 3 AA2 4 ILE A 65 THR A 66 -1 N ILE A 65 O LEU A 73 SHEET 4 AA2 4 LEU A 219 ALA A 220 1 O LEU A 219 N THR A 66 SHEET 1 AA3 2 PHE A 167 THR A 168 0 SHEET 2 AA3 2 GLY A 174 GLU A 176 -1 O ARG A 175 N PHE A 167 SHEET 1 AA4 5 ILE A 259 GLN A 265 0 SHEET 2 AA4 5 ALA A 246 ASP A 253 -1 N LEU A 249 O THR A 263 SHEET 3 AA4 5 ILE A 518 ASP A 525 -1 O ALA A 519 N MET A 252 SHEET 4 AA4 5 TYR A 503 ALA A 511 -1 N SER A 505 O ILE A 524 SHEET 5 AA4 5 ALA A 482 ARG A 489 -1 N LYS A 484 O ALA A 508 SHEET 1 AA5 2 ILE A 315 ASP A 317 0 SHEET 2 AA5 2 GLN A 339 ASP A 341 -1 O LEU A 340 N VAL A 316 SHEET 1 AA6 2 THR A 322 ILE A 325 0 SHEET 2 AA6 2 TYR A 328 ARG A 331 -1 O TYR A 328 N ILE A 325 SHEET 1 AA7 2 LYS A 430 SER A 431 0 SHEET 2 AA7 2 VAL A 446 GLN A 447 -1 O VAL A 446 N SER A 431 LINK OG SER A 294 C7 XVG A 601 1555 1555 1.50 CISPEP 1 GLN A 265 PRO A 266 0 -1.68 CISPEP 2 TYR A 319 PRO A 320 0 -1.24 CISPEP 3 ALA A 511 PRO A 512 0 -12.44 CRYST1 67.765 82.661 88.799 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014757 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012098 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011261 0.00000